BackgroundCheck.run
Search For

Clare L Murray, 524114 Thetford Rd, Durham, NC 27707

Known as:
Clare Louise Murray Clare L Hillhouse
Related to:
Claudia E Stevens 73

Clare Murray Phones & Addresses

4114 Thetford Rd, Durham, NC 27707    919-5237144   

200 Azalea Dr, Chapel Hill, NC 27514    919-9296121   

100 Avery, Chapel Hill, NC 27514    919-9296121   

6236 Enright Ave, Saint Louis, MO 63130   

605 Clara Ave, Saint Louis, MO 63112    314-4541348   

Get Report
Control this profile

Mentions for Clare L Murray

Clare Murray resumes & CV records

Resumes

Clare Murray Photo 29

Danish Institute Of Study

Location:
424 east 52Nd St, New York, NY 10022
Industry:
Financial Services
Work:
Leapfrog Investments Jun 2017 - Jan 2020
Associate Director Blackrock Aug 2013 - May 2017
Vice President - Institutional Sales and Impact Investing Blackrock Nov 2012 - Jul 2013
Associate - Corporate Strategy and Finance Goldman Sachs Jun 2010 - Nov 2012
Financial Investment Professional Charlotte In 2012 - Democratic National Convention 2012 - 2012
Fundraiser United Kingdom 2012 - 2012
Danish Institute of Study
Education:
Columbia Business School 2015 - 2017
Master of Business Administration, Masters Duke University 2006 - 2010
Bachelors, Bachelor of Arts, Art History, Art Danish Institute of Study 2008 - 2008
Ethical Culture Fieldston School 2002 - 2006
Skills:
Investments, Finance, Corporate Finance, Analysis, Business Development, Financial Analysis, Financial Modeling, Impact Investing, Socially Responsible Investing, Business Strategy, Equities, Capital Markets, Asset Management, Investor Relations
Interests:
Politics
Environment
Certifications:
Series 7
Series 66
Financial Industry Regulatory Authority (Finra)
Clare Murray Photo 30

Clare Murray

Clare Murray Photo 31

Clare Murray

Clare Murray Photo 32

Clare Murray

Clare Murray Photo 33

Manager At Scynexis Inc

Location:
Raleigh-Durham, North Carolina Area
Industry:
Pharmaceuticals

Publications & IP owners

Us Patents

Isoquinoline Compounds

US Patent:
2007014, Jun 21, 2007
Filed:
Jul 11, 2006
Appl. No.:
11/485172
Inventors:
Mitchell deLong - Raleigh NC, US
Marcos Sznaidman - Durham NC, US
Robert Oakley - Durham NC, US
Allen Eckhardt - Durham NC, US
Christine Hudson - Durham NC, US
Jeffrey Yingling - Apex NC, US
Michael Peel - Chapel Hill NC, US
Thomas Richardson - Durham NC, US
Clare Murray - Chapel Hill NC, US
Brian Heasley - Wake Forest NC, US
Paresma Patel - San Diego CA, US
Assignee:
Aerie Pharmaceuticals, Inc. - Research Triangle Park NC
International Classification:
A61K 31/47
US Classification:
514307000, 546146000
Abstract:
Isoquinoline compounds with G are provided that influence, inhibit or reduce the action of a G-protein receptor kinase. Pharmaceutical compositions including therapeutically effective amounts of the isoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, osteoporosis and glaucoma are also provided.

Isoquinoline Compounds

US Patent:
2009006, Mar 12, 2009
Filed:
Nov 20, 2008
Appl. No.:
12/274887
Inventors:
Mitchell A. deLong - Raleigh NC, US
Marcos L. Sznaidman - Durham NC, US
Robert H. Oakley - Durham NC, US
Allen E. Eckhardt - Durham NC, US
Christine Hudson - Durham NC, US
Jeffrey D. Yingling - Apex NC, US
Michael Peel - Chapel Hill NC, US
Thomas E. Richardson - Durham NC, US
Clare Louise Murray - Chapel Hill NC, US
Brian H. Heasley - Wake Forest NC, US
Paresma R. Patel - San Diego CA, US
Assignee:
Aerie Pharmaceuticals, Inc. - Research Triangle Park NC
International Classification:
A61K 31/47
C07D 217/22
A61P 27/02
A61P 9/00
A61P 1/00
A61P 15/08
A61P 35/00
A61P 19/08
C12N 5/00
US Classification:
514310, 546143, 435325
Abstract:
Isoquinoline compounds with G are provided that influence, inhibit or reduce the action of a G-protein receptor kinase. Pharmaceutical compositions including therapeutically effective amounts of the isoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, osteoporosis and glaucoma are also provided.

Isoquinoline Compounds

US Patent:
2010009, Apr 15, 2010
Filed:
Dec 16, 2009
Appl. No.:
12/639670
Inventors:
Mitchell A. deLong - Raleigh NC, US
Marcos L. Sznaidman - Durham NC, US
Robert H. Oakley - Durham NC, US
Allen E. Eckhardt - Durham NC, US
Christine Hudson - Durham NC, US
Jeffrey D. Yingling - Apex NC, US
Michael Peel - Chapel Hill NC, US
Thomas E. Richardson - Durham NC, US
Clare Louise Murray - Chapel Hill NC, US
Brian H. Heasley - Wake Forest NC, US
Paresma R. Patel - San Diego CA, US
Assignee:
AERIE PHARMACEUTICALS, INC. - Research Triangle Park NC
International Classification:
A61K 31/472
C07D 217/02
C07D 401/12
C12N 5/00
A61K 31/4725
A61P 27/02
A61P 19/00
A61P 9/00
A61P 13/12
US Classification:
514310, 546143, 435375
Abstract:
Isoquinoline compounds with G are provided that influence, inhibit or reduce the action of a G-protein receptor kinase. Pharmaceutical compositions including therapeutically effective amounts of the isoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, osteoporosis and glaucoma are also provided.

Hydrazide Compounds

US Patent:
2007013, Jun 14, 2007
Filed:
Jul 11, 2006
Appl. No.:
11/485182
Inventors:
Mitchell deLong - Raleigh NC, US
Marcos Sznaidman - Durham NC, US
Robert Oakley - Durham NC, US
Allen Eckhardt - Durham NC, US
Christine Hudson - Durham NC, US
Jeffrey Yingling - Apex NC, US
Michael Peel - Chapel Hill NC, US
Thomas Richardson - Durham NC, US
Clare Murray - Chapel Hill NC, US
Brian Heasley - Wake Forest NC, US
Paresma Patel - San Diego CA, US
Assignee:
Aerie Pharmaceuticals, Inc. - Research Triangle Park NC
International Classification:
A61K 31/44
US Classification:
514357000, 546332000
Abstract:
Hydrazide compounds with GPCR desensitization inhibitory activity are provided that may be used to influence, inhibit or reduce the action of a G-protein receptor kinase. Pharmaceutical compositions including therapeutically effective amounts of the hydrazide compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions controlled or influenced by GPCRs are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, osteoporosis and glaucoma are also provided.

Amido-Pyridyl Ether Compounds And Compositions And Their Use Against Parasites

US Patent:
2014017, Jun 26, 2014
Filed:
Jun 27, 2012
Appl. No.:
14/127248
Inventors:
Charles Q. Meng - Grayson GA, US
Clare Louise Murray - Chapel Hill NC, US
Mustapha Soukri - Raleigh NC, US
Mary George Johnson - Durham NC, US
Assignee:
MERIAL LIMITED - Duluth GA
International Classification:
A01N 43/40
US Classification:
514354, 546323
Abstract:
The subject matter disclosed herein is directed to amido-pyridyl ether compounds of formula I:wherein, R, R, R, R, R, R, R, R, R, R, R, R, a, b and d are as described herein, compositions comprising the compounds of formula I, methods for their preparation and methods for their uses against parasites.

Possible Relatives

Cynthia J Murray  David Murray  Dawn A Murray  Dayan S Murray  Dean A Murray  Deann R Murray  Deanna R Murray  Clare A Johnson  Clare E Johnston  Clare M Mcguire 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.